Skip to content
Uncapped with Jack AltmanUncapped with Jack Altman

Concentrating in Winners | Vince Hankes, Partner at Thrive Capital | Ep. 27

(If you enjoyed this, please like and subscribe!) Vince Hankes is a Partner at Thrive Capital where he’s worked on investments in OpenAI, SpaceX, Databricks, and Stripe among others. Vince invests across all stages and currently sits on the board of Airtable, Benchling, Console, Isomorphic, Lattice and Rogo. Prior to joining Thrive, Vince was an investor at Tiger Global. We covered: - Non-consensus investing - Writing billion dollar checks - Buying Carvana at the bottom - The value of compounding - What matters most to Thrive Timestamps: (0:00) Intro (0:50) The evolution of Thrive (4:22) Instagram, Github, and Stripe (7:57) Qualitative, then quantitative (9:39) Writing massive checks (16:48) Winning strategies in venture (25:58) Buying Carvana at the bottom (32:50) Managing conflicts (36:13) AI’s impact on the market (42:25) East meets West Coast investors (45:19) Vertical specific workspaces (49:53) Scale and timing of robotics (51:31) OpenAI vs everything else (55:59) What matters most for Thrive More on Vince: https://x.com/vhankes https://www.linkedin.com/in/vincent-hankes/ More on Jack: https://www.altcap.com/ https://x.com/jaltma https://linktr.ee/uncappedpod Email: friends@uncappedpod.com This episode is presented for informational purposes only and does not constitute investment advice or an offer to sell, or a solicitation of an offer to buy, any securities. The discussion herein similarly does not constitute a solicitation with respect to any Thrive fund or an offer of investment advisory services. Investments identified herein are discussed solely for illustrative purposes and there is no guarantee that current or future investments of Thrive will be similar in quality or kind.

Vince HankesguestJack Altmanhost
Oct 8, 202557mWatch on YouTube ↗

CHAPTERS

  1. Building conviction to write billion-dollar checks: years-long “wind-up”

    Vince explains that extreme concentration requires near-dogmatic conviction, which can’t be formed quickly. Thrive’s biggest checks often come after years of relationship-building and iterative learning with a company.

    • Writing $1B+ into a company demands unwavering conviction, not a “maybe” mindset
    • The diligence/relationship period can take years, not weeks
    • Stripe: first invested ~10 years before the ~$2B follow-on
    • Isomorphic: ~18 months of getting to know the team before investing
  2. Thrive’s evolution: from scrappy $10M beginnings to a scaled platform

    Jack and Vince walk through Thrive’s growth from a tiny 2009 fund into a multi-billion-dollar firm. Vince highlights how the firm felt small even at a billion-dollar fund, especially relative to his prior seat at Tiger.

    • Founded in 2009 with a ~$10M fund; now operates at much larger scale
    • When Vince joined (2019), Thrive had just raised ~$1B split across early + growth funds
    • Coming from Tiger’s larger pools made Thrive feel comparatively small
    • The firm was beginning to make “bigger bets” as it scaled
  3. New York outsider DNA and early talent selection

    Vince argues Thrive’s early New York positioning and “outsider” status shaped both its culture and its recruiting—attracting contrarian, self-selecting talent. As Thrive became more well-known, preserving that contrarian edge became harder and more intentional.

    • Josh Kushner started the firm at 26 in New York—unusual vs. Silicon Valley norms
    • Early hires were ‘misfits’ willing to bet on an unproven platform
    • Many standout investors came through Thrive’s early self-selection dynamic
    • Today, Thrive must proactively seek contrarian talent because inbound skews more consensus
  4. Origin of concentrated boldness: Instagram and GitHub as formative case studies

    Vince uses Instagram and GitHub to show that large, proportional bets and deep partnership have been core to Thrive since early days. These stories also reinforce how non-consensus moments can create opportunities to build conviction and ownership.

    • Instagram: Thrive invested nearly $20M from a ~$40M fund (huge concentration)
    • The Instagram deal boosted Thrive’s brand alongside marquee Valley firms
    • GitHub: CEO stepped down shortly after Thrive invested; company became non-consensus
    • Thrive leaned in through hands-on involvement (e.g., interim CFO support) and bought more
  5. Stripe’s 2023 “non-consensus” mega-round: long-term lens over short-term numbers

    Vince reframes Thrive’s Stripe investment as contrarian in context: post-COVID deceleration and skepticism about profitability and leadership. Thrive underwrote the long-term compounding of online commerce and deepened diligence beyond quarterly metrics, then helped syndicate the full raise.

    • Market skepticism post-COVID created fear around growth deceleration
    • Thrive focused on long-term e-commerce penetration rather than near-term forecasts
    • Deep engagement with founders and product reinforced conviction beyond numbers
    • Thrive put in ~$2B and helped raise the remainder in a difficult fundraising climate
  6. Thrive’s decision framework: qualitative-first, then quantitative confirmation

    Vince outlines Thrive’s sequencing: start with people, product, and customers to form a hypothesis, then validate with data. This approach is designed to keep conviction resilient through inevitable quarterly volatility.

    • Start with qualitative hypothesis; use quantitative data to confirm (not lead)
    • If you start with numbers, confidence collapses when metrics soften
    • Qualitative grounding enables better diagnosis when performance dips
    • Thrive’s ‘sweet spot’ is combining financial rigor with empathy for company-building
  7. Why Databricks was compelling: single-product to multi-product platform transition

    Vince describes Thrive’s Databricks investment as driven less by generic “AI tailwinds” and more by a platform inflection. The core bet: multi-product platform companies are structurally underpriced because they’re harder to build and scale than single-product businesses.

    • Thrive focused on the platform expansion, not just growth rates
    • Multi-product platforms can be worth much more than single-product companies
    • Transitions create mispricing because platform-building is difficult and rare
    • Late-stage diligence emphasized durable product and organizational evolution
  8. A concentrated growth fund by design: 10-company portfolios and power-law math

    Vince explains Thrive’s preference for highly concentrated growth funds—ideally around 10 companies—aligned with power-law outcomes. He argues it can be easier to identify a $10B company becoming $100B+ than to pick the right unicorn from thousands earlier on.

    • Ideal growth fund: ~10 companies, highly concentrated exposure
    • Goal: concentrate in ‘generational’ tech companies headed to $100B–$200B+
    • Power-law framing: odds improve when selecting from a smaller set of established leaders
    • Data point: growth in $100B+ companies outpaced growth in $10B companies over the decade
  9. Why winners are getting bigger: second-decade compounding, scale flywheels, and talent

    Vince attributes today’s mega-winners to compounding over decades, not sudden changes. The biggest enterprise value creation often occurs in a company’s second or third decade, when distribution, product expansion, and talent flywheels become self-reinforcing.

    • Compounding and maturity: many iconic companies are 10–15+ years old
    • Most enterprise value creation happens in the second/third decade
    • Scale advantages: distribution, product velocity, and customer reach reinforce leadership
    • Talent flywheel: top companies like OpenAI/SpaceX become magnets, raising competitive barriers
  10. What works in venture now: barbell strategy and skepticism of the crowded middle

    Vince describes Thrive’s barbell approach: early-stage where ownership and hands-on help can be high, and late-stage where platforms are clearer. He’s most wary of the mid-stage ‘breakout’ zone where large checks meet uncertainty and intense competition.

    • Early-stage remains attractive if you can identify great people and earn meaningful ownership
    • Late-stage works when the platform is solidified and data can validate durability
    • Mid-stage is crowded: many $500M–$2B companies are funded as if PMF is proven
    • Large $100M checks make ‘zeros’ far more painful, raising risk of capital loss
  11. Operating model at scale: few investors, few deals, and creating opportunities (not waiting)

    Vince explains why Thrive’s headcount and process look unusual: a small investing team makes relatively few commitments per person each year. The firm emphasizes proactive, relationship-driven investing—approaching companies with deep outside-in knowledge rather than waiting for a fundraising process.

    • ~75 employees but only ~8 investors; low deal volume per investor (~2–3/year)
    • Thrive ‘turns over rocks’ continuously but commits rarely
    • Competitive advantage: create the opportunity by building relationships before a process
    • Diligence goes beyond the CEO—meet product/engineering/sales to test alignment and information flow
  12. Scale as an advantage: the billion-dollar check narrows the competitive field

    Vince argues that the ability to write extremely large checks grants access and reduces competition versus mid-stage rounds. Thrive prefers competing in arenas with fewer capable firms, where time-intensive partnership is feasible and welcomed by companies.

    • Few firms can write $1B checks, so competition is narrower than in $10M/$100M rounds
    • Late-stage companies grant access/time primarily to credible large-check partners
    • The ‘Sand Hill pitch → 1 month diligence’ model is less competitive today
    • Scale, paired with conviction, becomes a defensible edge (for now)
  13. Carvana: contrarian public markets bet, organizational resilience, and doubling down at the bottom

    Vince recounts Thrive’s Carvana investment as a high-volatility test of their conviction culture. Thrive focused on product and operational levers during a cycle-driven collapse, then increased exposure when risk-reward improved—despite intense mark-to-market pressure.

    • Thrive knew Carvana from earlier relationships; acted when public pricing moved faster than private
    • Core thesis: logistics/infrastructure moat + product experience + scale flywheel
    • Stock drawdown was extreme (90%+), intensifying scrutiny and psychological difficulty
    • Doubling shares at far lower prices improved risk-adjusted exposure; operational progress reinforced conviction
  14. Full-stack investing tradeoffs: conflicts, commitment, and building new structures (AI accounting example)

    Vince discusses how Thrive manages conflicts given its concentrated approach and willingness to invest across stages (seed through public). He illustrates how full-stack thinking led Thrive to back an AI-enabled accounting service strategy and raise a dedicated holding-company vehicle to match the time horizon.

    • Concentration implies a strong commitment; conflicts are taken seriously
    • Full-stack investing means you may want exposure across many stages—raising conflict complexity
    • AI accounting: instead of only funding tools, Thrive pursued the service-provider model to capture value
    • Created a dedicated capital structure (holding company) suited to longer-duration, operational assets
  15. AI outlook: augmentation over full replacement, plus big bets in life science, codegen economics, vertical apps, and robotics

    Vince shares his AI worldview: many roles will be augmented rather than fully automated, though some functions (e.g., support) may shift heavily to software. He highlights life science as an underappreciated frontier, breaks down codegen’s value chain economics, assesses vertical AI workspaces, and frames robotics as a potentially massive but timing-uncertain opportunity.

    • AI likely makes people far more efficient; humans still matter in many workflows
    • Life science (Isomorphic): computational simulation of wet-lab work could reshape drug development; regulatory and trial pathways remain key constraints
    • Codegen stack: value accrues heavily to frontier models/compute; NVIDIA as major profit ‘toll taker’ today; app-layer unit economics still evolving
    • Vertical AI tools: surprising early adoption in law/medicine; competition is intense but breakout winners can consolidate
    • Robotics: enormous potential consumer market; debate on whether we’re near a breakthrough or in a ‘self-driving 2015’ phase

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.